The lowest price of the product zł940.00 in day 04.03.2025
Lowest price in the last 30 days: zł940.00
Juvéderm VOLUX uses Allergan's breakthrough VYCROSS technology, which enhances the cross-linking of formulations to create a highly bonded matrix.
field of application
Modeling, shaping and contouring of the chin and jaw area
Facial contouring
composition
Cross-linked hyaluronic acid 25mg/1ml
0.3% lidocaine hydrochloride
contraindications
Do not inject the product in the orbital area (eyelid, under-eye area, crow's feet) and plains.
Do not inject the product into blood vessels (intravascular),
Intravascular injection may cause embolization, vascular obstruction, ischemia or infarction.
Do not make too many corrections.
not recommended for use
In patients suffering from epilepsy that is not treated,
In patients with a tendency to produce hypertrophic scars,
In patients with known hypersensitivity to hyaluronic acid,
In patients with hypersensitivity to lidocaine or amide-type local anesthetics,
In patients suffering from porphyria,
In pregnant or breastfeeding women,
In children.
In areas with skin problems of inflammation and/or infection type (acne, herpes, etc.).
In direct combination with laser therapy, deep chemical peeling or dermabrasion.
For superficial peeling, injection is not recommended if it causes a severe inflammatory reaction.
The product may only be used by professionals.
By making a purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.
Dear Customer
The online store www.centerfillers.com is intended for professionals, people with education in the field of medicine, aesthetic medicine and for entrepreneurs interested in the store's products in connection with their business activity.
By going to the website www.centerfillers.com, I declare that I am aware that the content on the website is intended only for professionals and I am a person with education in the field of aesthetic medicine, or I am an entrepreneur interested in the offer as part of my business activity.
I confirmLeave this page
